Jan-Erik Löfroth

Title: Jan-Erik Löfroth: Innovator in Pharmaceutical Formulations

Introduction

Jan-Erik Löfroth is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on innovative solutions that enhance drug delivery and efficacy.

Latest Patents

Löfroth's latest patents include a film coating composition designed for pharmaceutical formulations. This composition provides modified release characteristics and consists of a dispersion that includes an acrylic polymer, a vinyl acetate polymer, and a water-containing liquid. The film coat is particularly useful for achieving modified release from various pharmaceutical formulations such as tablets and pellets. Another significant patent is a formulation for the treatment of thromboembolism. This new pharmaceutical formulation comprises the thrombin inhibitor HOOC—CH—(R)-Cgl-Aze-Pab combined with medium chain glycerides. It also details a process for preparing this formulation and its application in treating patients with thromboembolism.

Career Highlights

Throughout his career, Jan-Erik Löfroth has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Löfroth has collaborated with several professionals in his field, including Staffan Schantz and Anders Welin. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jan-Erik Löfroth is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact the treatment of various medical conditions. His innovative patents reflect his commitment to improving drug delivery systems and patient outcomes.